Relationship between antipsychotic drug use and behavioral and psychological symptoms of dementia in old people with cognitive impairment living in geriatric care

被引:70
作者
Lovheim, Hugo [1 ]
Sandman, Per-Olof
Kallin, Kristina
Karlsson, Stig
Gustafson, Yngve
机构
[1] Umea Univ, Dept Community Med & Rehabil, SE-90185 Umea, Sweden
[2] Umea Univ, Dept Nursing, Umea, Sweden
关键词
residential care; nursing home; dementia; BPSD; aggressiveness; sex difference; pharmacological treatment;
D O I
10.1017/S1041610206003930
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Behavioral and psychological symptoms of dementia (BPSD) commonly occur among cognitively impaired people in geriatric care. BPSD are often managed with antipsychotic drugs, despite the associated serious health risks. The aim of the present study was to discover factors associated with the use of antipsychotics. Methods: A cross-sectional study in all geriatric care units in the county of V sterbotten, Sweden, which included 2017 residents aged 65 years and over with cognitive impairment (mean age was 83.5 years). Data were collected from prescription records and observations made by care staff of BPSD among residents during the preceding week. A multivariate regression model was constructed to find factors independently associated with antipsychotic drug use. Results: Eleven factors were independently associated with the use of antipsychotics. Aggressive, verbally disruptive and wandering behavior, hallucinatory and depressive symptoms, male sex, living in a group dwelling for people with dementia, imposed mental workload, the ability to rise from a chair, activities of daily living (ADL) dependency and lower age all correlated significantly. Conclusions: Antipsychotic drug treatment of old people with cognitive impairment in geriatric care is common, and determined not only by the patient's symptoms but also by factors related more closely to the caregiver and the caring situation. These findings raise important questions about the indications for drug treatment in relation to the patient's quality of life.
引用
收藏
页码:713 / 726
页数:14
相关论文
共 31 条
[1]   PREVALENCE OF DEMENTIA DISORDERS IN INSTITUTIONALIZED SWEDISH OLD-PEOPLE - THE WORK LOAD IMPOSED BY CARING FOR THESE PATIENTS [J].
ADOLFSSON, R ;
GOTTFRIES, CG ;
NYSTROM, L ;
WINBLAD, B .
ACTA PSYCHIATRICA SCANDINAVICA, 1981, 63 (03) :225-244
[2]   A 1-year follow-up study of behavioral and psychological symptoms in dementia among people in care environments [J].
Ballard, CG ;
Margallo-Lana, M ;
Fossey, J ;
Reichelt, K ;
Myint, P ;
Potkins, D ;
O'Brien, J .
JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (08) :631-636
[3]  
Ballard CG, 2004, J CLIN PSYCHIAT, V65, P23
[4]  
Ballard CG, 2004, J CLIN PSYCHIAT, V65, P114
[5]   A systematic review of the association between the Behavioral and Psychological Symptoms of Dementia and burden of care [J].
Black, W ;
Almeida, OP .
INTERNATIONAL PSYCHOGERIATRICS, 2004, 16 (03) :295-315
[6]   Psychosis, depression and behavioural disturbances in Sydney nursing home residents: prevalence and predictors [J].
Brodaty, H ;
Draper, B ;
Saab, D ;
Low, LF ;
Richards, V ;
Paton, H ;
Lie, D .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2001, 16 (05) :504-512
[7]   A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia [J].
Brodaty, H ;
Ames, D ;
Snowdon, J ;
Woodward, M ;
Kirwan, J ;
Clarnette, R ;
Lee, E ;
Lyons, B ;
Grossman, F .
JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (02) :134-143
[8]   Antipsychotic medication for challenging behaviour in people with intellectual disability: a systematic review of randomized controlled trials [J].
Brylewski, J ;
Duggan, L .
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 1999, 43 :360-371
[9]   Factors influencing prescription of CNS medications in different elderly populations [J].
Craig, D ;
Passmore, AP ;
Fullerton, KJ ;
Beringer, TRO ;
Gilmore, DH ;
Crawford, VLS ;
McCaffrey, PM ;
Montgomery, A .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2003, 12 (05) :383-387
[10]   A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia [J].
De Deyn, PP ;
Rabheru, K ;
Rasmussen, A ;
Bocksberger, JP ;
Dautzenberg, PLJ ;
Eriksson, S ;
Lawlor, BA .
NEUROLOGY, 1999, 53 (05) :946-955